Renovaro Inc.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Renovaro Inc. and other ETFs, options, and stocks.

About RENB

Renovaro, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. 

CEO
David Weinstein
CEODavid Weinstein
Employees
25
Employees25
Headquarters
Los Angeles, California
HeadquartersLos Angeles, California
Founded
2011
Founded2011
Employees
25
Employees25

RENB Key Statistics

Market cap
61.36M
Market cap61.36M
Price-Earnings ratio
-0.37
Price-Earnings ratio-0.37
Dividend yield
—
Dividend yield—
Average volume
709.60K
Average volume709.60K
High today
$0.3849
High today$0.3849
Low today
$0.36
Low today$0.36
Open price
$0.37
Open price$0.37
Volume
525.32K
Volume525.32K
52 Week high
$2.34
52 Week high$2.34
52 Week low
$0.3214
52 Week low$0.3214
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.